A development stage biotechnology company engaged in the research and clinical development of biopharmaceutical products for the diagnosis and treatment of central nervous system diseases.


Updates from The Motley Fool

Latest updates on Alseres Pharmaceuticals, Inc. from Fool.com.

There is no available coverage of Alseres Pharmaceuticals, Inc. at this time.



Stock Performance

ALSE vs. S&P 500 | 2 Year Performance
View Interactive ALSE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alseres Pharmaceuticals, Inc..
Current Price: $120.00
Prev Close: $65.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $65.00 - $65.00
Volume: 0
Avg Vol 0
Market Cap: $735.24MM
P/E (ttm): -0.65
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alseres Pharmaceuticals, Inc..
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think Alseres Pharmaceuticals, Inc. will perform against the market?



You pick for Alseres Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Alseres Pharmaceuticals, Inc..

A development stage biotechnology company engaged in the research and clinical development of biopharmaceutical products for the diagnosis and treatment of central nervous system diseases.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Drug Makers